Disclaimer
The alfapump® system is currently not approved in Canada for commercial use. DSR® therapy is still in development and is currently not approved in the United States or Canada. Any statements regarding safety and efficacy arise from ongoing pre-clinical and clinical investigations which have yet to be completed. Sequana Medical makes no claims of safety or effectiveness of the DSR® therapy in the U.S. or Canada. There is no link between the DSR® therapy and ongoing investigations with the alfapump® system in Europe, the United States or Canada.
Below, you will find testimonials from a physician and various patients whose refractory ascites condition is managed with the alfapump® system. Interviewed patients that had been implanted with the alfapump® all indicated how it changed their lives in a positive way, by feeling better and being mobile and self-caring again.
We strongly encourage you to discuss this option with your physician or contact one of the reference centers which have adopted the alfapump® system in their practice.
Patient Michael B. received an alfapump® in 2012 and he has not looked back since. The alfapump® System helped Michael to improve his appetite and physical activity level. He responded so well to therapy that he is no longer being considered for a liver transplant.
It has been amazing, really!
“…once the alfapump was switched on it started to drawn the fluid away, it was set to a certain level, I think it was a litre a day to start off with, and things just got better fairly quickly.
… It has given me a new lease on life, essentially. Before, I was struggling with lack and breath, lack of appetite, not really wanting to do anything or being unable to do a lot of things, sleeping a lot. The alfapump® has removed the fluid that was surrounding my lungs and other organs and it has been amazing, really!”
United States
go to sequanamedical.com